No Data
No Data
H.C. Wainwright Maintains Zynex(ZYXI.US) With Buy Rating, Cuts Target Price to $8
RBC Capital Maintains Zynex(ZYXI.US) With Hold Rating, Cuts Target Price to $4
Zynex Inc Faces Challenges Amidst Revenue Decline
12 Health Care Stocks Moving In Wednesday's Intraday Session
Zynex Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results.
Express News | Zynex Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Financial Results